{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-000694","form_type":"8-K","ticker":"ZIVO","cik":"0001101026","company_name":"Zivo Bioscience, Inc.","filed_at":"2024-01-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.363944+00:00","generated_at":"2026-06-06T22:25:21.053515+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Zivo Bioscience sells 174,145 unregistered shares to accredited investors at avg $3.05/share","bullets":["Sold 174,145 common shares at $2.82–$4.02 each (avg $3.05), relying on Section 4(2) and Regulation D.","No underwriter discounts or commissions; transaction exempt from registration under Securities Act.","As of Jan 16, 2024, outstanding common shares totaled 2,748,167."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-000694","json":"https://secwatch.observer/filing/0001654954-24-000694.json","markdown":"https://secwatch.observer/filing/0001654954-24-000694.md","text":"https://secwatch.observer/filing/0001654954-24-000694.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424000694/0001654954-24-000694-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424000694/zivo_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T22:25:21.053515+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}